The accelerating program is co-runned by BE Health Ventures, which has been dedicated in healthtech and medtech for years, prestigious clinical institution- Show Chwan Health Care System, and IRCAD TAIWAN. Together, they are honored to be supported by the National Science and Technology Council for hosting the grand demo day.
Born to pioneers, the “innovative high-value medical devices incubating program” is targeting the profitable market.
On the demo day, several prominent guests were invited to deliver opening remarks, including Director General Andrea Hsu, Department of Academia-Industry Collaboration and Science Park Affairs, National Science and Technology Council. She encourages that “On today’s demo day, we look forward to the cooperation between hospitals and start-ups to develop innovative technologies.” Also, Arthur Chen, managing partner of BE Health Ventures, made an official launch of the “innovative high-value medical devices incubating program” at the event.
Being dedicated in the medical devices area for years, BE is fully aware of the importance for building an ecosystem of innovative high-value medical devices and CDMO. So, it meant a lot for BE to launch the program on the demo day, and to establish the foundation of Taiwan’s key role in worldwide innovation.
The CEO Janet Huang of Show Chwan Health Care System, who rarely appears in public, also specified the entrepreneurial story of his father, the president Huang Min-ho, to encourage start-ups: “Show Chwan Health Care System is the largest medical group founded by doctors in Taiwan. President Huang Min-ho started his business in Surgical Clinic. Along the way, it has grown to a medical system with eight hospitals at its current stage. We are born to pioneer and determined to go global, with the spirit, we have been supporting start-ups with resources of investment and mentorship, which are key essentials for start-ups to thrive.”
Top tier international surgical innovation experts, and inspiring dialogue with medical devices investors.
In addition to the demo of startups, BE and Show Chwan Health Care System especially organized a panel which invited prestigious speakers including Dr. Lee Swanstrom from the IHU Strasbourg, Dr. Luis Romagnolo from the Barretos Cancer Hospital, Dr. Michel Chu, president of ITIC, and Yen Chen Huang, vice president of Diamond Biofund. In the panel, they would cover the topic: “VC x MedTech: The Global Perspectives to Accelerate International Growth”, sharing the new trends of minimally invasive surgery and the possible ways to go global. Don’t miss out on the great opportunity to join the demo day and enjoy the inspiring panel!
Outstanding performance for medical innovation, let Taiwan be seen.
The combination of “Show Chwan Health Care System x IRCAD x BE” had jointly incubated startups of MIS medical technology, there are teams from the U.S., South Korea, Taiwan, and Singapore, covering fields ranging from AI precision medicine, AI disease prediction, big data analysis platform, nanotechnology treatment, intelligent care equipment, minimally invasive surgery image analysis, etc., and unlike usual, this time the oversea recruitment was up to 40%. Apart from the remarkable teams from the United States, Taiwan, and Singapore, the program also enrolled a Korean team for the very first time. This great achievement resulted from Taiwan’s abundant medical resources and Taiwan’s unique role in the global healthcare ecosystem as well.
The brilliant achievement of raising over 7M USD for U.S. start-up in a single round.
Advanced NanoTherapies (ANT), a U.S.-based start-up team with high market value potential, utilizes its drug-coated balloon (DCB) to safely release long-term drugs to treat Peripheral Arterial Disease (PAD), which is likely to hit double-digit annual revenue growth over the next decade. During the acceleration, BE Health Ventures and Show Chwan Health Care System linked investors and investment institutions from the United States, Canada, Europe, Asia and the Middle East, etc., and to support ANT in completing the new A round of USD 7M fundraising. At present, ANT is about to conduct clinical trials at O.S.U FIH in Australia in October this year, and afterwards they will conduct clinical research and consultations at Show Chwan Health Care System in Taiwan.
Being determined to go global, BE & Show Chwan envision the new blueprint for the innovation of medical devices.
BE Health Ventures and Show Chwan Health Care System, with the solid clinical background, help the Taiwan start-ups to go global, and connect oversea start-ups with Taiwan’s abundant medical resources.
Ever since 2019, BE Health Ventures and Show Chwan Health Care System jointly established the first health ventures in Taiwan, which focuses on supporting healthtech and medtech start-ups and building an worldwide innovation ecosystem. So far, they have funded 20 start-ups at home and abroad, with 2 portfolios already IPO successfully. And now, we launch the “innovative high-value medical devices incubating program” to envision a new blueprint for the innovation of medical devices. As CEO Janet Huang of Show Chwan Health Care System mentioned, “we are born to pioneer and determined to go global”, BE Health Ventures and Show Chwan Health Care System encourage start-ups to go global, and to show the world Taiwan’s extraordinary medical expertise and capability.
Media Contact
Company Name: BE Health Venture
Contact Person: PollyChen
Email: Send Email
Country: Taiwan
Website: https://www.beaccelerator.com.tw/
